Clinical trial
Long-term Follow-up of Measles Antibodies
NCT00168571 · Bandim Health Project, Other · Completed
Key facts
| NCT number | NCT00168571 |
|---|---|
| Title | Long-term Follow-up of Measles Antibodies |
| Official title | Long-term Follow-up of Protective Measles Antibodies in the Two-dose Study of Standard-titre Measles Vaccine in Guinea-Bissau |
| Lead sponsor | Bandim Health Project, Other |
| Collaborators | Danish Council for Development Research Novo Nordisk A/S Industry Fonden til Lægevidenskabens Fremme Medical Research Council Unit, The Gambia |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Measles |
| Intervention type | Biological |
| Interventions | Measles vaccine |
| Enrollment | 1,960 |
| Start date | Mar 1, 2002 |
| Completion | Jan 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Sep 22, 2011 |
| Countries | Guinea-Bissau |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: